Muscle & Nerve · 1995 · 57 citations · 26 references
MedicineNeurologyNeuroscienceNeuroimmunologyNeuromuscular DisordersNeuropathologyAutoimmune Neurological DisordersDemyelinating DiseasesDemyelinating DisordersMotor NeuropathyPeripheral Nerve DisordersPeripheral NeuropathiesImmune-mediated DemyelinationMotor DeficitsMotor Function DeficitsPeripheral Demyelinating NeuropathySensory-motor Neuropathy
Chronic inflammatory demyelinating polyneuropathy (CIDP) is usually characterized by prominent motor deficits. A pure sensory presentation, labeled chronic sensory demyelinating neuropathy (CSDN), has been reported, but it is unclear if this neuropathy is a distinct clinical and immunologic entity or merely the sensory presentation of the more usual sensorimotor CIDP. We describe 5 patients with what initially appeared to be CSDN; 3 subsequently developed substantial weakness coincident with the electrophysiologic appearance of multifocal motor conduction block. These cases indicate that, in some cases, CSDN may be a transitional clinical stage of CIDP in which the more usual sensorimotor deficits develop later. Immune-based therapy, including intravenous immunoglobulin, was found to be effective in both the pure sensory and sensorimotor types.
26
Chronic Inflammatory Polyradiculoneuropathy
J Gordon Millichap · Pediatric Neurology Briefs · 1997 · 823 citations · Full text
Medicine, Neurology, Pediatrics +11
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Richard J. Barohn · Archives of Neurology · 1989 · 570 citations
Medicine, Neurology, Neuroscience +12
Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome
Atsuro Chiba, Susumu Kusunoki, Teruo Shimizu et al. · Annals of Neurology · 1992 · 566 citations
Life Sciences, Immunology, Neurology +15
Robert C. Griggs · Archives of Neurology · 1994 · 473 citations